Evan Tzanis
Directeur des opérations chez Neuraptive Therapeutics, Inc.
Postes actifs de Evan Tzanis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Directeur des opérations | 24/10/2022 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2019 | 24/10/2022 |
Historique de carrière de Evan Tzanis
Anciens postes connus de Evan Tzanis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Corporate Officer/Principal | 01/06/2014 | 01/08/2014 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2014 | - |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |
- Bourse
- Insiders
- Evan Tzanis
- Expérience
